Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | GLP1R | P43220 | 1/20 | 0.39 |
| ▸ | SCTR | P47872 | 1/20 | 0.39 |
| ▸ | GRPR | P30550 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | APC | P25054 | 1/20 | 0.38 |
| ▸ | MC4R | P32245 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29748370 | 0.88 | MC4R (0.45) | F2GLP1RSCTRMC4R | |
| SCHEMBL31757510 | 0.88 | OPRM1 (0.37) | F2OPRM1OPRD1OPRK1KEAP1 | |
| SCHEMBL30082002 | 0.88 | ERAP2 (0.43) | PTPN1 | |
| SCHEMBL31031611 | 0.87 | GRPR (0.44) | F2OPRM1OPRD1OPRK1GLP1R | |
| SCHEMBL29833409 | 0.87 | ERAP2 (0.44) | PTPN1 | |
| SCHEMBL31756925 | 0.87 | PTPN1 (0.40) | PTPN1 | |
| SCHEMBL31241620 | 0.87 | OPRD1 (0.42) | OPRM1OPRD1OPRK1 | |
| SCHEMBL30974346 | 0.86 | OPRM1 (0.41) | F2OPRM1OPRD1OPRK1PTPN1 | |
| SCHEMBL30254260 | 0.86 | OPRM1 (0.48) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL7599777 | 0.86 | ERAP2 (0.44) | PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117343136-A | Preparation of ginseng oligopeptide and compound thereof and application of ginseng oligopeptide and compound thereof in treatment of alcoholic liver injury diseases | 大连深蓝肽科技研发有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-117257923-A | Composition for treating cat liver injury and preparation method and application thereof | 大连深蓝肽科技研发有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-117343136-B | Preparation of ginseng oligopeptide and compound thereof and application of ginseng oligopeptide and compound thereof in treatment of alcoholic liver injury diseases | 大连深蓝肽科技研发有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-117343136-B | Preparation of ginseng oligopeptide and compound thereof and application of ginseng oligopeptide and compound thereof in treatment of alcoholic liver injury diseases | 大连深蓝肽科技研发有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-117343136-A | Preparation of ginseng oligopeptide and compound thereof and application of ginseng oligopeptide and compound thereof in treatment of alcoholic liver injury diseases | 大连深蓝肽科技研发有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117343136-A | Preparation of ginseng oligopeptide and compound thereof and application of ginseng oligopeptide and compound thereof in treatment of alcoholic liver injury diseases | 大连深蓝肽科技研发有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117257923-A | Composition for treating cat liver injury and preparation method and application thereof | 大连深蓝肽科技研发有限公司 | 2023-12-22 | — | — | CN | disclosed |